These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 28964914)

  • 1. Imatinib mesylate-induced cardiomyopathy involves resident cardiac progenitors.
    Savi M; Frati C; Cavalli S; Graiani G; Galati S; Buschini A; Madeddu D; Falco A; Prezioso L; Mazzaschi G; Galaverna F; Lagrasta CAM; Corradini E; De Angelis A; Cappetta D; Berrino L; Aversa F; Quaini F; Urbanek K
    Pharmacol Res; 2018 Jan; 127():15-25. PubMed ID: 28964914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sab mediates mitochondrial dysfunction involved in imatinib mesylate-induced cardiotoxicity.
    Chambers TP; Santiesteban L; Gomez D; Chambers JW
    Toxicology; 2017 May; 382():24-35. PubMed ID: 28315715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice.
    Knight B; Tirnitz-Parker JE; Olynyk JK
    Gastroenterology; 2008 Sep; 135(3):969-79, 979.e1. PubMed ID: 18602920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SIRT1 activation rescues doxorubicin-induced loss of functional competence of human cardiac progenitor cells.
    De Angelis A; Piegari E; Cappetta D; Russo R; Esposito G; Ciuffreda LP; Ferraiolo FA; Frati C; Fagnoni F; Berrino L; Quaini F; Rossi F; Urbanek K
    Int J Cardiol; 2015; 189():30-44. PubMed ID: 25889431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imatinib mesylate attenuates myocardial remodeling through inhibition of platelet-derived growth factor and transforming growth factor activation in a rat model of hypertension.
    Jang SW; Ihm SH; Choo EH; Kim OR; Chang K; Park CS; Kim HY; Seung KB
    Hypertension; 2014 Jun; 63(6):1228-34. PubMed ID: 24591339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the genotoxicity of the tyrosine kinase inhibitor imatinib mesylate in cultured fish and human cells.
    Novak M; Žegura B; Nunić J; Gajski G; Gerić M; Garaj-Vrhovac V; Filipič M
    Mutat Res Genet Toxicol Environ Mutagen; 2017 Feb; 814():14-21. PubMed ID: 28137363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-Resistant Cardiac Progenitor Cells Modified With Apurinic/Apyrimidinic Endonuclease/Redox Factor 1 Gene Overexpression Regulate Cardiac Repair After Myocardial Infarction.
    Aonuma T; Takehara N; Maruyama K; Kabara M; Matsuki M; Yamauchi A; Kawabe J; Hasebe N
    Stem Cells Transl Med; 2016 Aug; 5(8):1067-78. PubMed ID: 27334489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.
    De Angelis A; Piegari E; Cappetta D; Marino L; Filippelli A; Berrino L; Ferreira-Martins J; Zheng H; Hosoda T; Rota M; Urbanek K; Kajstura J; Leri A; Rossi F; Anversa P
    Circulation; 2010 Jan; 121(2):276-92. PubMed ID: 20038740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery as nanoparticles reduces imatinib mesylate-induced cardiotoxicity and improves anticancer activity.
    Marslin G; Revina AM; Khandelwal VK; Balakumar K; Prakash J; Franklin G; Sheeba CJ
    Int J Nanomedicine; 2015; 10():3163-70. PubMed ID: 25995626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imatinib attenuates end-organ damage in hypertensive homozygous TGR(mRen2)27 rats.
    Schellings MW; Baumann M; van Leeuwen RE; Duisters RF; Janssen SH; Schroen B; Peutz-Kootstra CJ; Heymans S; Pinto YM
    Hypertension; 2006 Mar; 47(3):467-74. PubMed ID: 16432052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib mesylate effects on zebrafish reproductive success: Gonadal development, gamete quality, fertility, embryo-larvae viability and development, and related genes.
    Ahmadi N; Samaee SM; Yokel RA; Tehrani A
    Toxicol Appl Pharmacol; 2019 Sep; 379():114645. PubMed ID: 31278918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.
    Uziel O; Fenig E; Nordenberg J; Beery E; Reshef H; Sandbank J; Birenbaum M; Bakhanashvili M; Yerushalmi R; Luria D; Lahav M
    Br J Cancer; 2005 May; 92(10):1881-91. PubMed ID: 15870711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon γ is a STAT1-dependent direct inducer of BCL6 expression in imatinib-treated chronic myeloid leukemia cells.
    Madapura HS; Nagy N; Ujvari D; Kallas T; Kröhnke MCL; Amu S; Björkholm M; Stenke L; Mandal PK; McMurray JS; Keszei M; Westerberg LS; Cheng H; Xue F; Klein G; Klein E; Salamon D
    Oncogene; 2017 Aug; 36(32):4619-4628. PubMed ID: 28368400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat.
    Piegari E; Russo R; Cappetta D; Esposito G; Urbanek K; Dell'Aversana C; Altucci L; Berrino L; Rossi F; De Angelis A
    Oncotarget; 2016 Sep; 7(38):62312-62326. PubMed ID: 27694688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hiding inside? Intracellular expression of non-glycosylated c-kit protein in cardiac progenitor cells.
    Shi H; Drummond CA; Fan X; Haller ST; Liu J; Malhotra D; Tian J
    Stem Cell Res; 2016 May; 16(3):795-806. PubMed ID: 27161312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferation effect of imatinib mesylate on MCF7, T-47D tumorigenic and MCF 10A nontumorigenic breast cell lines via PDGFR-β, PDGF-BB, c-Kit and SCF genes.
    Kadivar A; Kamalidehghan B; Akbari Javar H; Karimi B; Sedghi R; Noordin MI
    Drug Des Devel Ther; 2017; 11():469-481. PubMed ID: 28260860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Outcome of Administration of c-kit(POS) Cardiac Progenitor Cells After Acute Myocardial Infarction: Transplanted Cells Do not Become Cardiomyocytes, but Structural and Functional Improvement and Proliferation of Endogenous Cells Persist for at Least One Year.
    Tang XL; Li Q; Rokosh G; Sanganalmath SK; Chen N; Ou Q; Stowers H; Hunt G; Bolli R
    Circ Res; 2016 Apr; 118(7):1091-105. PubMed ID: 26838790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opposing roles of KIT and ABL1 in the therapeutic response of gastrointestinal stromal tumor (GIST) cells to imatinib mesylate.
    Rausch JL; Boichuk S; Ali AA; Patil SS; Liu L; Lee DM; Brown MF; Makielski KR; Liu Y; Taguchi T; Kuan SF; Duensing A
    Oncotarget; 2017 Jan; 8(3):4471-4483. PubMed ID: 27965460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy.
    Cappetta D; Esposito G; Piegari E; Russo R; Ciuffreda LP; Rivellino A; Berrino L; Rossi F; De Angelis A; Urbanek K
    Int J Cardiol; 2016 Feb; 205():99-110. PubMed ID: 26730840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells in Phenotypic Screening: A Transforming Growth Factor-β Type 1 Receptor Kinase Inhibitor Induces Efficient Cardiac Differentiation.
    Drowley L; Koonce C; Peel S; Jonebring A; Plowright AT; Kattman SJ; Andersson H; Anson B; Swanson BJ; Wang QD; Brolen G
    Stem Cells Transl Med; 2016 Feb; 5(2):164-74. PubMed ID: 26683871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.